Novus Therapeutics

$0.7308
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0492 (-6.31%) Today
$0.00 (0.00%) As of 3:57 PM EDT after-hours

Why Robinhood?

You can buy or sell NVUS and other stocks, options, ETFs, and crypto commission-free!

About NVUS

Novus Therapeutics, Inc. Common Stock, also called Novus Therapeutics, is a pharmaceutical company, which engages in the acquisition, development, and commercialization of products for disorders of the ear, nose, and throat. Read More Its product pipelines include OPO201; OP0101; and OP0102. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.

Employees
10
Headquarters
Irvine, California
Founded
2004
Market Cap
9.48M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
41.70K
High Today
$0.80
Low Today
$0.73
Open Price
$0.80
Volume
45.13K
52 Week High
$5.47
52 Week Low
$0.7101

Collections

NVUS Earnings

-$0.52
-$0.44
-$0.37
-$0.29
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.42 per share
Actual
-$0.35 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.